Zobrazeno 1 - 10
of 903
pro vyhledávání: '"Metastatic lung cancer"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract This review provides a comprehensive analysis of apoptotic signaling pathways in the context of bone metastatic lung cancer, emphasizing the intricate molecular mechanisms and microenvironmental influences. Beginning with an overview of apop
Externí odkaz:
https://doaj.org/article/8d859fe3d7924581980f463de8b43526
Autor:
Jack Lofroth, Amir Pourghadiri, Anastasia Hadjivassiliou, Manraj Heran, Gerald Legiehn, Stephen Ho, Ravjot Dhatt
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3978-3984 (2024)
Inferior vena cava (IVC) compression secondary to mass effect is accompanied by edema, ascites, back and abdominal pain, and central nervous system symptoms. Most IVC syndrome cases described in the literature focus on the focal treatment of IVC lesi
Externí odkaz:
https://doaj.org/article/8f6160336c054cd7ae1226b40198949d
Publikováno v:
Diyala Journal of Medicine, Vol 26, Iss 2 (2024)
Background: Adenocarcinoma of the lung is the most common type of lung cancer. Platinum agents in combination with other chemotherapy are currently the cornerstone for chemotherapy of advanced cases with metastasis. Objective: To compare the respo
Externí odkaz:
https://doaj.org/article/66d0b0fdb0af426c96804a12a9944f9d
Autor:
Seul-Ki Mun, Hyun Bo Sim, Ji Yeon Han, Hyeongyeong Kim, Dae-Han Park, Dong-Jo Chang, Sung-Tae Yee, Young-Tae Chang, Jong-Jin Kim
Publikováno v:
Tomography, Vol 9, Iss 4, Pp 1187-1195 (2023)
The development of efficient biomarkers and probes for monitoring and treating cancer, specifically metastatic cancer, is a critical research area that can have a significant impact on both patient outcomes and drug discovery. In this context, TiNIR
Externí odkaz:
https://doaj.org/article/4ab1bb8c93eb445b9a85c7d4f6b4b7a8
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 2971-2977 (2022)
Myriam Koch,1 Frederike Rasch,1 Tobias Rothammer,1 Karolina Müller,2 Arno Mohr,3 Michael Koller,2 Christian Schulz1 1Department of Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany; 2Center for Clinical Studies, University Hos
Externí odkaz:
https://doaj.org/article/50d9df77506348fb89f6b2920d6a7e62
Autor:
Mariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, Virginia Calvo, Enric Carcereny, Alexandra Cantero, Reyes Bernabé, Gretel Benitez, Rafael López Castro, Bartomeu Massutí, Edel del Barco, Rosario García Campelo, Maria Guirado, Carlos Camps, Ana Laura Ortega, Jose Luis González Larriba, Alfredo Sánchez, Joaquín Casal, M. Angeles Sala, Oscar Juan-Vidal, Joaquim Bosch-Barrera, Juana Oramas, Manuel Dómine, Jose Manuel Trigo, Remei Blanco, Julia Calzas, Idoia Morilla, Airam Padilla, Joao Pimentao, Pedro A. Sousa, Maria Torrente
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself.
Externí odkaz:
https://doaj.org/article/0111fe9f31fa49208eab155d42059c73
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 2041-2052 (2022)
Elisei Moise Hasan,1 Crenguta Livia Calma,2 Anca Tudor,3 Corina Vernic,3 Emanuel Palade,4,5 Emanuela Tudorache,6 Cristian Oancea,6 Ion Papava7 1“Victor Babeș” University of Medicine and Pharmacy, Timișoara, Romania; 2Department of Functional Sc
Externí odkaz:
https://doaj.org/article/c82402339b274be39f91ad9a3d8ac03a
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1156 (2023)
A metastatic brain tumor is the most common type of malignancy in the central nervous system, which is one of the leading causes of death in patients with lung cancer. The purpose of this study is to evaluate the efficacy of a novel treatment for met
Externí odkaz:
https://doaj.org/article/e06a10c6564944a3bf98923a922c5d58
Autor:
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, Chike O. Abana, Kewen He, Duygu Sezen, Mark Wasley, Fatemeh Masrorpour, Dawei Chen, Liangpeng Yang, Joe D. Dunn, Saumil Gandhi, Quynh-Nhu Nguyen, Maria Angelica Cortez, James W. Welsh
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Combining radiotherapy with PD1 blockade has had impressive antitumor effects in preclinical models of metastatic lung cancer, although anti-PD1 resistance remains problematic. Here, we report results from a triple-combination the
Externí odkaz:
https://doaj.org/article/07dc075fcbd049008b2e635b70dfaf0b
Publikováno v:
Современная онкология, Vol 23, Iss 3, Pp 428-435 (2021)
Nowadays immunotherapy is a crucial option in the treatment of non-small cell lung cancer. There are a lot of actual options of the first-line therapy for the patients with metastatic lung cancer, including dual immunological blockade of PD-1/PD-L1 a
Externí odkaz:
https://doaj.org/article/a92e51c914374d90b0dcf921ac158329